Earnings Update: Aurora, Canopy Growth, Canopy Rivers And Zynerba Each Post ResultsBenzinga • 11/09/20
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational HighlightsGlobeNewsWire • 11/09/20
Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th Annual Child Neurology Society (CNS) MeetingGlobeNewsWire • 10/15/20
New Data Describing Statistically Significant Results from the Phase 2 BRIGHT Trial in Patients with Autism Spectrum Disorder (ASD) Presented at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th Annual Child Neurology Society (CNGlobeNewsWire • 10/15/20
Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACAP) 2020 Annual MeetingGlobeNewsWire • 10/08/20
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Virtual Joint 49th Annual Child Neurology Society & 16th International Child Neurology Society Congress (CNS-ICNA) MeetingGlobeNewsWire • 10/08/20
Zynerba Pharmaceuticals - Whether They've Cracked The Code For Fully Methylated FX Syndrome PatientsSeeking Alpha • 09/24/20
Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion SyndromeGlobeNewsWire • 09/17/20
Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor ConferencesGlobeNewsWire • 09/10/20
Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational HighlightsGlobeNewsWire • 08/10/20
Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth ConferenceGlobeNewsWire • 08/06/20
Zynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 07/29/20
Zynerba Pharmaceuticals to Present an Update on the Zygel™ Development Program at the 17th NFXF International Fragile X Conference Research RoundupGlobeNewsWire • 07/22/20
Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X SyndromeGlobeNewsWire • 06/30/20